예방접종의 경제성 평가방법과 사례
Economic evaluation of v accinations - a methodologic review
1
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
The basis of the economic evaluation of vaccination is the balance between the use of the resources (input) and the improvements that result from the vaccination (output). Techniques used for economic evaluation of vaccination are cost analysis, cost-minimization analysis, cost-effectiveness analysis, cost-utility analysis and cost-benefit analysis. Cost analysis seeks to characterize the costs of a given vaccination program. Cost-effective analysis is to helps policy-makers decide on the best use of allocated resources, whether costbenefit analysis is to helps policy-makers decide on the overall allocation of resources. Cost-utility analysis is a specific form of cost-effective analysis in which outcomes are reduced to a common denominator such as the quality-adjusted life year (QALY) or disability- adjusted life year (DALY). Many economic analyses have been conducted on vaccines in the world, but there have been a little studies on economic evaluation on vaccines in Korea. This paper reviewed the methodology used to economic evaluation on vaccines and immunizations and addressed some examples of the methods. (Korean J Pediatr Infect Dis 2008;15:19-28)
Abstract
The basis of the economic evaluation of vaccination is the balance between the use of the resources (input) and the improvements that result from the vaccination (output). Techniques used for economic evaluation of vaccination are cost analysis, cost-minimization analysis, cost-effectiveness analysis, cost-utility analysis and cost-benefit analysis. Cost analysis seeks to characterize the costs of a given vaccination program. Cost-effective analysis is to helps policy-makers decide on the best use of allocated resources, whether costbenefit analysis is to helps policy-makers decide on the overall allocation of resources. Cost-utility analysis is a specific form of cost-effective analysis in which outcomes are reduced to a common denominator such as the quality-adjusted life year (QALY) or disability- adjusted life year (DALY). Many economic analyses have been conducted on vaccines in the world, but there have been a little studies on economic evaluation on vaccines in Korea. This paper reviewed the methodology used to economic evaluation on vaccines and immunizations and addressed some examples of the methods. (Korean J Pediatr Infect Dis 2008;15:19-28)
참고문헌 (11)
- Szucs TD, "Health economic research on vaccinations and immunisation practices.an introductory primer", Vaccine, 23, pp.2095~2103 (2005)
- Drummond M, "Do we fully understand the economic value of vaccines?", Vaccine, 25, pp.5945~5957 (2007)
- Jefferson T, "Do vaccines make best use of available resources?", Vaccine, 17(3), pp.S69~S73 (1999)
- Chun, BC, "Cost-Benefit Analysis of influenza vaccination among Korean elderly. Doctoral thesis" (2000), Graduate School of Korea University
- Drummond MF, "Methods for the Economic Evaluation of Health Care Programmes" (2005), Oxford University Press
- Choi, Sun-Ja, "Disease burden and Economic costs Analysis of Community-Acquired Pneumonia:Estimation from the Korea National Health Insurance Claims Database. Master of Public Health Thesis (Supervised by Chun, Byung Chul)", School of Public Health Korea University (2007)
- Chun, BC, "Impact and economic burden of a pandemic influenza in Korea", Proceedings of Influenza and Pandemic influenza 2008 (2008)
- Chun, BC, "A cost-minimization analysis of Hepatitis B Virus Screening and Vaccination Program to the Newly Employed Health Care Workers in General Hospitals", Proceedings of 2002 Spring Conference of Korean Society of Preventive Medicine (2002)
- Laupacis A, "How attractive does a new technology have to be to warrant adoption and utilisation?", 4Chun BC, Methods for the Economic Evaluation of Health Care Programmes6Choi Sun-Ja, pp.Disease burden and Economic costs Analysis of Community-Acquired Pneumonia:Estimation from the Korea National Health Insurance Claims Database. Master of Public Health Thesis (Supervised by Chun Byung Chul)7Chun BC, Impact and economic burden of a pandemic influenza in Korea8Chun BC[DOI]
- Stratton KR, "Vaccines for the 21st Century: a tool for decision making" (2000), National Academy Press
- Diseases Burden of H. influenzae Type b (Hib) and Immunogenicity of Hib Vaccine, "Kim, KH", KCDC, ~ (2007)
